PT Diagnos Laboratorium Utama Tbk(ID:DGNS)
Rp292.00+4.00 (+1.39%)
ID:DGNS
PT Diagnos Laboratorium Utama Tbk financials statements
Rp292.00
At close:+4.00 (+1.39%)
PT Diagnos Laboratorium Utama Tbk (DGNS) Ratios
PT Diagnos Laboratorium Utama Tbk Ratios
ID:DGNS's free cash flow for Q2 2026 was Rp-2.60B. For the 2026 fiscal year, ID:DGNS's free cash flow was decreased by Rp-431.94M and operating cash flow was Rp-2.16B. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.30 | 3.64 | 6.08 | 11.28 | 5.78 |
| Quick Ratio | 3.08 | 3.40 | 5.72 | 10.66 | 5.49 |
| Cash Ratio | 0.31 | 0.19 | 0.71 | 2.67 | 1.68 |
| Solvency Ratio | 0.12 | 0.15 | 0.01 | 0.88 | 1.79 |
| Operating Cash Flow Ratio | 0.39 | 1.26 | 0.91 | -0.57 | 2.21 |
| Short-Term Operating Cash Flow Coverage | 1.46 | 4.80 | 3.10 | -1.45 | 19.85 |
| Net Current Asset Value | Rp -23.48B | Rp -25.28B | Rp 11.92B | Rp 88.86B | Rp 113.68B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.25 | 0.24 | 0.21 | 0.06 | 0.05 |
| Debt-to-Equity Ratio | 0.39 | 0.37 | 0.29 | 0.07 | 0.06 |
| Debt-to-Capital Ratio | 0.28 | 0.27 | 0.22 | 0.07 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.19 | 0.13 | 0.04 | 0.01 |
| Financial Leverage Ratio | 1.56 | 1.53 | 1.39 | 1.14 | 1.20 |
| Debt Service Coverage Ratio | 1.72 | 2.51 | 0.31 | 5.39 | 24.23 |
| Interest Coverage Ratio | 6.55 | 2.51 | -29.53 | 21.59 | 0.00 |
| Debt to Market Cap | 0.25 | 0.21 | 0.11 | 0.04 | 0.01 |
| Interest Debt Per Share | 64.02 | 58.37 | 45.79 | 12.41 | 9.45 |
| Net Debt to EBITDA | 4.32 | 4.08 | 30.33 | -0.42 | -0.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.98% | 39.54% | 40.71% | 45.83% | 48.86% |
| EBIT Margin | 3.05% | 1.07% | -8.99% | 9.41% | 27.56% |
| EBITDA Margin | 9.84% | 10.20% | 1.05% | 16.27% | 30.06% |
| Operating Profit Margin | 3.05% | 1.36% | -9.63% | 9.15% | 26.90% |
| Pretax Profit Margin | 3.24% | 0.53% | -9.32% | 8.99% | 27.56% |
| Net Profit Margin | 1.76% | 0.46% | -9.37% | 6.57% | 21.28% |
| Continuous Operations Profit Margin | 1.76% | 0.46% | -9.37% | 6.57% | 21.28% |
| Net Income Per EBT | 54.33% | 86.53% | 100.61% | 73.07% | 77.21% |
| EBT Per EBIT | 106.37% | 38.98% | 96.72% | 98.16% | 102.46% |
| Return on Assets (ROA) | 0.92% | 0.25% | -5.03% | 5.28% | 26.57% |
| Return on Equity (ROE) | 1.44% | 0.38% | -6.98% | 6.02% | 31.86% |
| Return on Capital Employed (ROCE) | 1.75% | 0.80% | -5.46% | 7.70% | 37.74% |
| Return on Invested Capital (ROIC) | 0.93% | 0.67% | -5.37% | 5.52% | 28.43% |
| Return on Tangible Assets | 0.93% | 0.25% | -5.04% | 5.29% | 26.57% |
| Earnings Yield | 1.28% | 0.31% | -4.44% | 4.15% | 6.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.94 | 3.34 | 3.22 | 3.90 | 4.09 |
| Payables Turnover | 10.65 | 10.32 | 14.18 | 33.95 | 34.16 |
| Inventory Turnover | 15.63 | 19.55 | 16.80 | 15.91 | 19.91 |
| Fixed Asset Turnover | 0.80 | 0.81 | 0.89 | 1.77 | 3.47 |
| Asset Turnover | 0.52 | 0.54 | 0.54 | 0.80 | 1.25 |
| Working Capital Turnover Ratio | 2.76 | 2.50 | 1.61 | 1.64 | 3.00 |
| Cash Conversion Cycle | 113.29 | 92.74 | 109.36 | 105.77 | 96.95 |
| Days of Sales Outstanding | 124.21 | 109.43 | 113.37 | 93.58 | 89.31 |
| Days of Inventory Outstanding | 23.36 | 18.67 | 21.73 | 22.94 | 18.33 |
| Days of Payables Outstanding | 34.27 | 35.36 | 25.73 | 10.75 | 10.68 |
| Operating Cycle | 147.57 | 128.10 | 135.09 | 116.52 | 107.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 8.53 | 21.84 | 10.55 | -4.81 | 47.47 |
| Free Cash Flow Per Share | 2.07 | -12.88 | -20.11 | -32.70 | -7.23 |
| Dividend Paid and CapEx Coverage Ratio | 1.32 | 0.63 | 0.34 | -0.17 | 0.80 |
| Capital Expenditure Coverage Ratio | 1.32 | 0.63 | 0.34 | -0.17 | 0.87 |
| Operating Cash Flow Coverage Ratio | 0.13 | 0.38 | 0.23 | -0.41 | 5.02 |
| Operating Cash Flow to Sales Ratio | 0.06 | 0.17 | 0.09 | -0.03 | 0.19 |
| Free Cash Flow Yield | 1.12% | -6.60% | -8.18% | -13.40% | -0.97% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 78.30 | 325.00 | -22.53 | 24.09 | 14.37 |
| Price-to-Sales (P/S) Ratio | 1.38 | 1.49 | 2.11 | 1.58 | 3.06 |
| Price-to-Book (P/B) Ratio | 1.13 | 1.24 | 1.57 | 1.45 | 4.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 88.98 | -15.14 | -12.23 | -7.46 | -103.06 |
| Price-to-Operating Cash Flow Ratio | 21.58 | 8.93 | 23.32 | -50.70 | 15.70 |
| Price-to-Earnings Growth (PEG) Ratio | 0.27 | -3.08 | 0.11 | -0.30 | 0.63 |
| Enterprise Value Multiple | 18.34 | 18.74 | 230.81 | 9.29 | 9.81 |
| Enterprise Value | 300.77B | 311.63B | 354.02B | 291.68B | 891.09B |
| EV to EBITDA | 18.34 | 18.74 | 230.81 | 9.29 | 9.81 |
| EV to Sales | 1.81 | 1.91 | 2.43 | 1.51 | 2.95 |
| EV to Free Cash Flow | 116.37 | -19.36 | -14.08 | -7.14 | -99.38 |
| EV to Operating Cash Flow | 28.22 | 11.42 | 26.85 | -48.49 | 15.14 |
| Tangible Book Value Per Share | 161.86 | 155.82 | 155.90 | 167.80 | 162.69 |
| Shareholders’ Equity Per Share | 163.19 | 156.91 | 156.47 | 168.34 | 162.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.46 | 0.13 | -0.01 | 0.27 | 0.23 |
| Revenue Per Share | 133.30 | 130.46 | 116.56 | 154.31 | 243.62 |
| Net Income Per Share | 2.35 | 0.60 | -10.92 | 10.13 | 51.84 |
| Tax Burden | 0.54 | 0.87 | 1.01 | 0.73 | 0.77 |
| Interest Burden | 1.06 | 0.49 | 1.04 | 0.95 | 1.00 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.39 | 0.38 | 0.50 | 0.41 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 3.63 | 36.52 | -0.97 | -0.48 | 0.92 |
Currency in IDR
